Drug/Medical Device
Aspreva Pharmaceuticals Corporation (ASPV)
| Date: | Jan 12, 2008 |
|---|---|
| Format: | |
| Price: | $70.00 |
Abstract
The Aspreva Pharmaceuticals Corporation (ASPV) Drug/Medical Device report provides unparalleled insights into its performance and risk through making available 3 key pieces of data: (1) product/candidate pipeline, (2) product/candidate regulatory status, and (3) product/candidate pipeline diversification. The report includes a detailed presentation of each drug/device candidate's indication, its clinical trial status (i.e. preclinical, Phase 1, Phase 2, Phase 3, NDA/BLA Filed, IDE Filed, 510K/PMA Filed, Approvable Letter Received), and its mechanism of action. In addition, the report identifies the strategic disease focus of Aspreva Pharmaceuticals Corporation and outlines its pipeline diversification across various disease sectors and sub-sectors (i.e. Cardiology, Oncology, Neurology, Immunology, Urology, etc.).
Report Contents
- Overview
- Product Summary
- Business Description
- Technical Summary
- Company Highlights
- Drug/Medical Device Details
- Industry/Sector Participation
- Product details
- Indications/Side Effects/Approval Details
Companies Mentioned in the Report
More Information:
Learn more about Drug/Medical Device Report.